Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-dose versus low-dose valproic acid as a prophylactic medication

K Taylor1, J Goldstein

  • 1San Francisco Headache Clinic, CA 94109, USA.

Headache
|September 1, 1996
PubMed
Summary

Lower doses of valproic acid may effectively prevent migraines. This case report suggests that 500 mg daily could be as effective as 1000 mg for migraine prophylaxis, warranting further dose-ranging studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of abnormal proliferation in histologically 'normal' colonic biopsies using FTIR-microspectroscopy.

Scandinavian journal of gastroenterology·2004
Same author

Fourier transform infrared microspectroscopy as a quantitative diagnostic tool for assignment of premalignancy grading in cervical neoplasia.

Journal of biomedical optics·2004
Same author

Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine.

Neurology·2004
Same author

Search for Kaluza-Klein graviton emission in pp collisions at square root[s] = 1.8 TeV using the missing energy signature.

Physical review letters·2004
Same author

Search for pair production of scalar top quarks in R-parity violating decay modes in pp collisions at square root of s=1.8 TeV.

Physical review letters·2004
Same author

Measurement of prompt charm meson production cross sections in pp collisions at square root s = 1.96 TeV.

Physical review letters·2003

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Valproic acid is recognized for its efficacy in migraine prophylaxis.
  • Its mechanism involves inhibiting gamma-aminobutyric acid transaminase.
  • Optimal therapeutic dosing for migraine prevention remains undetermined.

Observation:

  • A case report details a 24-year-old woman with chronic headaches treated with valproic acid.
  • Initial treatment at 1000 mg/day resolved headaches for two months.
  • Upon recurrence after tapering, a 500 mg/day dose also successfully resolved headaches.

Findings:

  • Lower dosages of valproic acid may achieve similar efficacy to higher doses in headache prophylaxis.
  • The patient found the 500 mg/day dose equally effective to the 1000 mg/day dose.

Implications:

  • Further research is needed to establish optimal dose ranges for valproic acid in migraine prophylaxis.
  • Correlating specific daily dosages with patient effectiveness is crucial for personalized treatment strategies.

Related Experiment Videos